[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![Merus N.V. Common Shares Graphic](https://lunarcrush.com/gi/w:26/t:$mrus.png) Merus N.V. Common Shares (MRUS)

Genmab to acquire Merus for $X billion, sending shares soaring. Positive clinical trial data and the acquisition have driven the stock to a 1-year high.

### About Merus N.V. Common Shares
Merus N.V. Common Shares (MRUS) is a biopharmaceutical company developing cancer therapeutics.  
Merus N.V. Common Shares uses the ticker $MRUS for trading. Listed in the [Stocks](/list/stocks) and  category within the [Healthcare](/list/stocks/healthcare) sectors.

### Insights [#](/topic/$mrus/insights)
- Merus N.V. Common Shares (MRUS) social dominance hit XXXX which is XXX% higher than it's daily average.
- Merus N.V. Common Shares (MRUS) social dominance is up XXXXXXXX% from the previous month.
- Merus N.V. Common Shares (MRUS) galaxy score™ is up XXXXXX% from the previous month.
- Merus N.V. Common Shares (MRUS) sentiment is up XXX% from the previous week.
- Merus N.V. Common Shares (MRUS) posts created is up XXXXXX% from the previous month.

### Price: $XXXXX [#](/topic/$mrus/close)
---
![Price Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:close/iv:1d.svg)  
[Price 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/close.tsv)  
The XXXXX% price surge in MRUS is driven by positive clinical trial results, analyst upgrades, and high social media engagement, with the stock price currently at $84.80, hitting a 1-year high, and the positive news indicates a likely continuation of the upward trend.  

| 24-Hour | 7-Day | 30-Day |
| ------- | ----- | ------ |
| XXXX%   | XXXX% | XXXXX% |

**1-Year High**: $XX on 2025-10-15  
**1-Year Low**: $XXXXX on 2025-04-08  
  
  
### AltRank: XXX [#](/topic/$mrus/alt_rank)
---
![AltRank Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:alt_rank/iv:1d.svg)  
[AltRank 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/alt_rank.tsv)  
Merus N.V. Common Shares (MRUS) is currently AltRank #478 based on combined combined social and market metrics
**Daily Average**: XXX  
**1 Week**: XXX +239  
**1 Month**: XXX -XXXXX  
**6 Months**: XXX -XXXXX  
**1 Year**: XXX +103  
**1-Year High**: XXXXX on 2025-08-12  
**1-Year Low**: XX on 2025-05-25  
  
  
### Galaxy Score: XX [#](/topic/$mrus/galaxy_score)
---
![Galaxy Score Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:galaxy_score/iv:1d.svg)  
[Galaxy Score 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/galaxy_score.tsv)  
**Current Value**: XX  
**Daily Average**: XX  
**1 Week**: XX +42  
**1 Month**: XX +61  
**6 Months**: XX +24  
**1 Year**: XX +49  
**1-Year High**: XX on 2025-07-10  
**1-Year Low**: XX on 2025-09-19  
  
  
### Engagements: XXXXXX [#](/topic/$mrus/interactions)
---
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:interactions/iv:1d.svg)  
[Engagements 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/interactions.tsv)  
**Current Value**: XXXXXX  
**Daily Average**: XXXXXX  
**1 Week**: XXXXXX -XX%  
**1 Month**: XXXXXXXXX +339%  
**6 Months**: XXXXXXXXX +221%  
**1 Year**: XXXXXXXXX -XX%  
**1-Year High**: XXXXXXX on 2025-09-29  
**1-Year Low**: XXX on 2025-10-20  

| Social Network | X      | YouTube | Reddit |
| -------------- | -      | ------- | ------ |
| Engagements    | XXXXXX | X       | X      |
  

  
  
### Mentions: XX [#](/topic/$mrus/posts_active)
---
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:posts_active/iv:1d.svg)  
[Mentions 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/posts_active.tsv)  
**Current Value**: XX  
**Daily Average**: XXX  
**1 Month**: XXX +105%  
**6 Months**: XXXXX +332%  
**1 Year**: XXXXX +545%  
**1-Year High**: XXXXX on 2025-07-10  
**1-Year Low**: X on 2025-10-20  

| Social Network | X   | YouTube | Reddit |
| -------------- | -   | ------- | ------ |
| Mentions       | XXX | X       | X      |
  

  
  
### Creators: XX [#](/topic/$mrus/contributors_active)
---
![Creators Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:contributors_active/iv:1d.svg)  
[Creators 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/contributors_active.tsv)  
XX unique social accounts have posts mentioning Merus N.V. Common Shares (MRUS) in the last XX hours which is down XX% from XX in the previous XX hours
**Daily Average**: XX  
**1 Month**: XXX +217%  
**6 Months**: XXXXX +738%  
**1 Year**: XXXXX +737%  
**1-Year High**: XXX on 2025-09-30  
**1-Year Low**: X on 2025-10-20  

The most influential creators that mention Merus N.V. Common Shares in the last XX hours

| Creator                                              | Rank | Followers | Posts | Engagements |
| -------                                              | ---- | --------- | ----- | ----------- |
| [@MarcJacksonLA](/creator/twitter/MarcJacksonLA)     | X    | XXXXX     | X     | XXX         |
| [@SamFazeli8](/creator/twitter/SamFazeli8)           | X    | XXXXX     | X     | XXX         |
| [@MichelleF_Davis](/creator/twitter/MichelleF_Davis) | X    | XXXXX     | X     | XXX         |
| [@PersimmonTI](/creator/twitter/PersimmonTI)         | X    | XXXXXX    | X     | XX          |
| [@jfais20](/creator/twitter/jfais20)                 | X    | XXXXXX    | X     | XX          |
| [@Fredbenz0](/creator/twitter/Fredbenz0)             | X    | XXXXX     | X     | XX          |
| [@EgidiusLambrech](/creator/twitter/EgidiusLambrech) | X    | XXX       | X     | XX          |
| [@SteveDJacobs](/creator/twitter/SteveDJacobs)       | X    | XXXXX     | X     | XX          |
| [@Biobeats99](/creator/twitter/Biobeats99)           | X    | XXX       | X     | XX          |
| [@TheOptionsBull2](/creator/twitter/TheOptionsBull2) | XX   | XXX       | X     | XX          |

[View More](/list/creators/$mrus/100)
  
  
### Sentiment: XX% [#](/topic/$mrus/sentiment)
---
![Sentiment Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:sentiment/iv:1d.svg)  
[Sentiment 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/sentiment.tsv)  
**Current Value**: XX%  
**Daily Average**: XX%  
**1 Week**: XXX% +50%  
**1 Month**: XXX% +25%  
**6 Months**: XXX% no change  
**1 Year**: XXX% +25%  
**1-Year High**: XXX% on 2025-01-26  
**1-Year Low**: X% on 2024-11-17  

**Most Supportive Themes**
- **Positive Clinical Trial Data:** (60%) Positive clinical trial results of Merus's drug, petosemtamab, particularly its high response and survival rates in head and neck cancer patients.
- **Analyst Price Target Increases:** (20%) Several social media posts highlight analysts raising price targets for MRUS based on the promising clinical trial data.
- **Acquisition by Genmab:** (15%) Genmab is acquiring Merus for $XX per share in cash, a deal valued at $X billion.
  
**Most Critical Themes**
- **Trial Data Comparison Concerns:** (1%)  Some users are expressing concerns over comparing trial results with different patient populations and treatment contexts.
  
Network engagement breakdown:  
| Network | Positive | %   | Neutral | %   | Negative | %  |
| ------- | -------- | -   | ------- | -   | -------- | -  |
| X       | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
| YouTube | X        | X%  | X       | X%  | X        | X% |
| Reddit  | X        | X%  | X       | X%  | X        | X% |
|         |          |     |         |     |          |    |
| Total   | XXXXX    | XX% | XXXXX   | XX% | XX       | X% |
  

  
  
### Social Dominance: XXXXXXX% [#](/topic/$mrus/social_dominance)
---
![Social Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:social_dominance/iv:1d.svg)  
[Social Dominance 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/social_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: XXXXX%  
**1 Week**: XXXXXX% +0.0022%  
**1 Month**: XXXX% +0.047%  
**6 Months**: XXXX% +0.043%  
**1 Year**: XXXX% +0.045%  
**1-Year High**: XXXX% on 2025-05-25  
**1-Year Low**: XXXXXX% on 2025-09-22  
  
  
### Market Dominance: XXXXXXX% [#](/topic/$mrus/market_dominance)
---
![Market Dominance Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:market_dominance/iv:1d.svg)  
[Market Dominance 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/market_dominance.tsv)  
**Current Value**: XXXXXXX%  
**Daily Average**: X%  
**1-Year High**: XXXXX% on 2025-03-31  
**1-Year Low**: XXXXXXX% on 2025-02-14  
  
  
### Market Cap: $XXXXXXXXXXXXX [#](/topic/$mrus/market_cap)
---
![Market Cap Line Chart](https://lunarcrush.com/gi/w:600/t:$mrus/c:line/m:market_cap/iv:1d.svg)  
[Market Cap 24-Hour Time-Series Raw Data](/topic/$mrus/time-series/market_cap.tsv)  
**Current Value**: $XXXXXXXXXXXXX  
**Daily Average**: $XXXXXXXXXXXXX  
**1 Week**: $XXXXXXXXXXXXX +$0.68%  
**1 Month**: $XXXXXXXXXXXXX +$39%  
**6 Months**: $XXXXXXXXXXXXX +$141%  
**1 Year**: $XXXXXXXXXXXXX +$100%  
**1-Year High**: $XXXXXXXXXXXXX on 2025-10-15  
**1-Year Low**: $XXXXXXXXXXXXX on 2025-04-08  

**Top assets mentioned**
In the posts about Merus N.V. Common Shares in the last XX hours

[Bitcoin Incognito (XBI)](/topic/$xbi)
[Metsera, Inc. Common Stock (MTSR)](/topic/$mtsr)
[Akropolis (AKRO)](/topic/$akro)
[Landwolf (WOLF)](/topic/$wolf)
[Johnson & Johnson (JNJ)](/topic/johnson-johnson)
[Avidity Biosciences, Inc. Common Stock (RNA)](/topic/$rna)
[AstraZeneca PLC (AZN)](/topic/$azn)
[Pfizer, Inc. (PFE)](/topic/$pfe)
[Merck & Co., Inc. (MRK)](/topic/$mrk)

**Top topics mentioned**
In the posts about Merus N.V. Common Shares in the last XX hours

[$gmab](/topic/$gmab), [$gmabco](/topic/$gmabco), [acquisition](/topic/acquisition), [stocks technology](/topic/stocks-technology), [$8b](/topic/$8b), [stocks healthcare](/topic/stocks-healthcare), [stocks](/topic/stocks), [$xbi](/topic/$xbi), [$psnl](/topic/$psnl), [stocks financial services](/topic/stocks-financial-services), [$mtsr](/topic/$mtsr), [$akro](/topic/$akro), [$etnb](/topic/$etnb), [investment](/topic/investment), [breakthrough](/topic/breakthrough), [$wolf](/topic/$wolf), [stocks bitcoin treasuries](/topic/stocks-bitcoin-treasuries), [johnson johnson](/topic/johnson-johnson), [$rna](/topic/$rna), [$argx](/topic/$argx), [$asnd](/topic/$asnd), [stocks real estate](/topic/stocks-real-estate), [$azn](/topic/$azn), [$pfe](/topic/$pfe), [$mrk](/topic/$mrk), [stocks communication services](/topic/stocks-communication-services), [investments](/topic/investments), [$abvx](/topic/$abvx), [$mstr](/topic/$mstr), [$crdo](/topic/$crdo), [$pltr](/topic/$pltr), [summary](/topic/summary), [ticker](/topic/ticker), [combo](/topic/combo), [exit](/topic/exit), [dawn protocol](/topic/dawn-protocol), [coins defi](/topic/coins-defi), [$cart](/topic/$cart), [$tlry](/topic/$tlry), [$jnj](/topic/$jnj), [$etor](/topic/$etor), [$fro](/topic/$fro), [$tmc](/topic/$tmc), [$arct](/topic/$arct), [$ewtx](/topic/$ewtx), [$mdgl](/topic/$mdgl), [$idya](/topic/$idya), [$apge](/topic/$apge), [$bntx](/topic/$bntx), [$sobi](/topic/$sobi), [$as](/topic/$as), [$asml](/topic/$asml), [stocks banks](/topic/stocks-banks), [$frmi](/topic/$frmi), [$lgo](/topic/$lgo), [stocks consumer cyclical](/topic/stocks-consumer-cyclical), [advanced micro devices](/topic/advanced-micro-devices), [electronic arts inc](/topic/electronic-arts-inc), [$pcvx](/topic/$pcvx), [$ptct](/topic/$ptct), [costa rican colon](/topic/costa-rican-colon), [$mltx](/topic/$mltx), [$adct](/topic/$adct), [sarepta therapeutics inc](/topic/sarepta-therapeutics-inc), [$8bn](/topic/$8bn), [$55bn](/topic/$55bn), [debt](/topic/debt), [$97shr](/topic/$97shr), [bloomberg](/topic/bloomberg), [upside](/topic/upside), [$dwtx](/topic/$dwtx), [corporate finance](/topic/corporate-finance), [$80b](/topic/$80b), [all the](/topic/all-the), [bank of](/topic/bank-of), [$idyas](/topic/$idyas), [$1325sh](/topic/$1325sh), [akro akero therapeutics inc](/topic/akro-akero-therapeutics-inc), [novo](/topic/novo), [$novcde](/topic/$novcde), [$52b](/topic/$52b), [$54share](/topic/$54share), [$ymab](/topic/$ymab), [$sndx](/topic/$sndx), [$adv](/topic/$adv), [has been](/topic/has-been), [$zec](/topic/$zec), [gilead sciences](/topic/gilead-sciences), [$roiv](/topic/$roiv), [atai life](/topic/atai-life), [jacob](/topic/jacob), [$caba](/topic/$caba), [$vrna](/topic/$vrna), [$vyne](/topic/$vyne), [$insm](/topic/$insm), [aa](/topic/aa), [overnight](/topic/overnight), [scoop](/topic/scoop), [$mens](/topic/$mens), [$ford](/topic/$ford)

### Top Social Posts [#](/topic/$mrus/posts)
---
Top posts by engagements in the last XX hours

*Showing only X posts for non-authenticated requests. Use your API key in requests for full results.*

"$JNJ $MRUS $GMAB $MRK ESMO 2025: J&J brings a new Rybrevant use into the fold - After promising early data in head and neck J&J plans a new phase X Origami-5 -"  
[X Link](https://x.com/MarcJacksonLA/status/1979938716895662258) [@MarcJacksonLA](/creator/x/MarcJacksonLA) 2025-10-19T15:52Z 7583 followers, XXX engagements


"$JNJ amivantamab an impressive XX% cORR in R/M. HNSCC. Slightly improved from the abstract. Starting a 1st line XXX patient P3 without CPS restrictions $GMAB $MRUS"  
[X Link](https://x.com/bio_clouseau/status/1979938503598186543) [@bio_clouseau](/creator/x/bio_clouseau) 2025-10-19T15:51Z 20K followers, 8582 engagements


"$MRUS showing consolidation 📉 with multiple UltraBuy signals 🚀 Are we gearing up for a breakout 💭 #UltraAlgo #Trading"  
[Reddit Link](https://redd.it/1ntln3w) [@Short_Algo](/creator/reddit/Short_Algo) 2025-10-19T07:56Z X followers, X engagements


"📈 US Exchanges 52-Week New Highs: $ATAI Atai Life Sciences N V $REKR Rekor Systems $CCO Clear Channel Outdoor $GILD Gilead Sciences $DGXX Digi Power X $ROIV Roivant Sciences $ASX Ase Industrial Holding $CVS CVS $MNST Monster Beverage $EL Estee Laudermpanies $MNMD Mind Medicine Mindmed $MRUS Merus N V CS $BG Bunge $XERS Xeris Pharmaceuticals $FIGS Figs #stockinfocus"  
[X Link](https://x.com/aipatternlab/status/1979571124909294014) [@aipatternlab](/creator/x/aipatternlab) 2025-10-18T15:31Z 4271 followers, XXX engagements